Notably, CSA is a robust inhibitor of CXCL10-induced NFATc1 activation, a mechanism by which CXCL10 regulates the recruitment of inflammatory cells in rheumatoid arthritis (20). The gene discussed is CXCL10; the disease is rheumatoid arthritis.